Irina Isakova–Sivak

Author

Irina Isakova–Sivak

Institute of Experimental Medicine ORCID

Also Known As

I ISAKOVA-SIVAK, I N Isakova, I N Isakova-Sivak, I. Isakova-Sivak, I. N. Isakova-Sivak, I.N. Isakova-Sivak, Irina N. Isakova-Sivak, Irina Isakova, Irina Isakova-Sivak, Irina Isakova–Sivak

119

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Institute of Experimental Medicine Research Institute of Influenza Centers for Disease Control and Prevention Program for Appropriate Technology in Health Georgia State University

About

Irina Isakova–Sivak is an author at Institute of Experimental Medicine specializing in medicine, vaccination, and influenza vaccines.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	21	677
2	Immunology	14	20	637
3	Allergy	3	3	62
4	Cell Biology	1	1	43
5	Epidemiology	1	1	25

Irina Isakova–Sivak

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
The development of vaccine viruses against pandemic A(H1N1) influenza James S. Robertson, Carolyn Nicolson, Ruth Harvey, Vaccine VaccinationVaccine VirusesVaccine TargetImmunologyVirology	2011	109
Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2) Irina Isakova–Sivak, Li-Mei Chen, Yumiko Matsuoka, Virology VaccinationViral EvolutionVaccine DevelopmentMedicineImmunology	2011	108
Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories Larisa Rudenko, Leena Yeolekar, Irina Kiseleva, Vaccine	2016	60
Assessment of Human Immune Responses to H7 Avian Influenza Virus of Pandemic Potential: Results from a Placebo–Controlled, Randomized Double–Blind Phase I Study of Live Attenuated H7N3 Influenza Vaccine Larisa Rudenko, Irina Kiseleva, Anatoly Naykhin, PLoS ONE	2014	57
Comparative Immunogenicity and Cross-Clade Protective Efficacy of Mammalian Cell-Grown Inactivated and Live Attenuated H5N1 Reassortant Vaccines in Ferrets Kortney M. Gustin, Taronna R. Maines, Jessica A. Belser, The Journal of Infectious Diseases Veterinary VaccineImmunologyImmunodominanceViral EvolutionCross-clade Protection	2011	43
H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial Larisa Rudenko, Irina Isakova–Sivak, Anatoly Naykhin, The Lancet Infectious Diseases VaccinologyVaccinationVaccine SafetyVaccine DevelopmentVaccine Efficacy	2015	40
Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin Irina Isakova–Sivak, Daniil Korenkov, Tatiana Smolonogina, Virology VaccinationCross-protectionImmunologyChimeric HemagglutininVirology	2018	37
Influenza vaccine: progress in a vaccine that elicits a broad immune response Irina Isakova–Sivak, Ekaterina Stepanova, Daria Mezhenskaya, Expert Review of Vaccines	2021	36
H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets Jørgen de Jonge, Irina Isakova–Sivak, Harry van Dijken, Molecular Therapy VaccinationUniversal Influenza VaccineSpecies BarrierVaccine DevelopmentHighly Immunogenic	2016	34
H7N3 live attenuated influenza vaccine has a potential to protect against new H7N9 avian influenza virus Larisa Rudenko, Irina Isakova–Sivak, Svetlana Donina Vaccine VaccinationVaccine DevelopmentVaccine TargetImmunologyVirology	2013	32

Page 1